NSC |
Compound |
Enrichment |
Correlation |
NSC 703111 |
Null |
0.0459335986102872 |
0.23636705 |
NSC 704281 |
Null |
0.0459335986102872 |
0.24856558 |
NSC 708422 |
Null |
0.0459335986102872 |
0.42150519 |
NSC 709438 |
Null |
0.0459335986102872 |
0.66128562 |
NSC 720174 |
Null |
0.0459335986102872 |
-0.35514224 |
NSC 725191 |
1,6-bis[(1S,4R,5R,8R,12R,13S)-1,5-dimethyl-10-(trifluorometh yl)-11,14,15,16-tetraoxatetracyclo[10.3.1.04,13.08,13]hexade c-9-en-9-yl]-3-hexene-1,6-diol |
0.0459335986102872 |
0.42015399 |
NSC 731201 |
ethyl 6,7-dichloro-3-phenyl-2-quinoxalincarboxylate 1,4-dioxide |
0.0459335986102872 |
0.07060109 |
NSC 734562 |
6-(3-Aminopropyl)-9-bromo-5,6-dihydro-3-nitro-5,11-dioxo-11H -indeno[1,2-c]isoquinoline Hydrochloride |
0.0459335986102872 |
0.30256762 |
NSC 735540 |
5-fluoro-N-(2-methyl-3-oxo-8-phenyl-1-thia-4-azaspiro[4.5]de c-4-yl)-3-phenyl-1H-indole-2-carboxamide |
0.0459335986102872 |
0.38486475 |
NSC 763646 |
(E)-2-(2-(benzo[d][1,3]dioxol-5-yl)vinyl)-5-(3-methyl-1H-pyrazol-5-yl)-1,3,4-oxadiazole |
0.0459335986102872 |
0.47428218 |